Clinical Trial Update: Metoclopramide as Treatment of Clozapine-induced Hypersalivation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metoclopramide for treating clozapine-induced hypersalivation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clozapine-induced Hypersalivation

Drugs mentioned

• Metoclopramide (metoclopramide)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Clozapine-induced Hypersalivation | Phase 3 | Status: COMPLETED